Literature DB >> 19687742

Valsartan inhibits NPC cell line CNE-2 proliferation and invasion and promotes its sensitivity to radiation.

Qiong Wang1, Wei Zhao, Gang Wu.   

Abstract

The objective of this study was to investigate the effects of angiotensin II and valsartan, an angiotensin II type 1 receptor (AT1R) blocker, combined with γ-radiation, on vascular endothelial growth factor (VEGF) expression, radiosensitivity, invasive potential, and proliferation activity of nasopharyngeal carcinoma (CNE-2) in vitro. Reverse-transcription PCR and ELISA assayed VEGF expression and secretion in CNE-2 in vitro. Radiosensitization of valsartan on CNE-2 cell in vitro was investigated by a colony-forming assay. The effect of AT1R blocker combined with radiation on invasive potential of CNE-2 cells was evaluated using 24-well Matrigel invasion chambers (Transwell). The apoptosis-inducing effect of valsartan combined with irradiation on apoptosis of CNE-2 was identified by flow cytometry. AT1R was expressed in nasopharyngeal carcinoma cell lines CNE-1 and CNE-2. The expression and secretion of VEGF in CNE-2 could be induced either by angiotensin II or γ-radiation. Furthermore, the suppression of AT1R activation reduced cellular proliferation, invasive potential and resistance to γ-radiation in nasopharyngeal carcinoma cells. In conclusion, AT1R plays a significant role not only in proliferation and invasion, but also in radiation resistance in nasopharyngeal carcinoma cells, the mechanism of which may be involved in the regulation of VEGF expression and secretion.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19687742     DOI: 10.1097/CEJ.0b013e32832f9c00

Source DB:  PubMed          Journal:  Eur J Cancer Prev        ISSN: 0959-8278            Impact factor:   2.497


  3 in total

Review 1.  Biomarkers for enhancing the radiosensitivity of nasopharyngeal carcinoma.

Authors:  Wei Chen; Guo-Hua Hu
Journal:  Cancer Biol Med       Date:  2015-03       Impact factor: 4.248

2.  MiR-200c increases the radiosensitivity of non-small-cell lung cancer cell line A549 by targeting VEGF-VEGFR2 pathway.

Authors:  Liangliang Shi; Sheng Zhang; Hongge Wu; Lilin Zhang; Xiaofang Dai; Jianli Hu; Jun Xue; Tao Liu; Yichen Liang; Gang Wu
Journal:  PLoS One       Date:  2013-10-30       Impact factor: 3.240

3.  Pre-treatment with angiotensin-(1-7) inhibits tumor growth via autophagy by downregulating PI3K/Akt/mTOR signaling in human nasopharyngeal carcinoma xenografts.

Authors:  Yu-Tsai Lin; Hung-Chen Wang; Hui-Ching Chuang; Yi-Chiang Hsu; Ming-Yu Yang; Chih-Yen Chien
Journal:  J Mol Med (Berl)       Date:  2018-10-29       Impact factor: 4.599

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.